beta-Ray treatment of malignant epibulbar melanoma
Sixty-eight patients suffering from conjunctival melanoma were treated by beta-irradiation. The dose given ranged between 15,000 and 20,000 rd at the tumor surface. In 75% the therapy was successful. In 67,4% the melanoma could be cured by beta-irradiation alone with a follow-up period between three...
Gespeichert in:
| Veröffentlicht in: | Albrecht von Graefes Archiv f r Klinische und Experimentelle Ophthalmologie 1978-12, Vol.209 (2), p.111-124 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 124 |
|---|---|
| container_issue | 2 |
| container_start_page | 111 |
| container_title | Albrecht von Graefes Archiv f r Klinische und Experimentelle Ophthalmologie |
| container_volume | 209 |
| creator | Lommatzsch, P K |
| description | Sixty-eight patients suffering from conjunctival melanoma were treated by beta-irradiation. The dose given ranged between 15,000 and 20,000 rd at the tumor surface. In 75% the therapy was successful. In 67,4% the melanoma could be cured by beta-irradiation alone with a follow-up period between three and ten years. The lethality rate from proven metastases was only 6.2%. The regression time after beta-therapy, as a rule, exceeded several months. Beta-rays can be used either primarily or after tumor excision. Care should be taken that the applicator covers all the tissue containing tumor cells. |
| doi_str_mv | 10.1007/BF00407844 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF00407844</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>74351291</sourcerecordid><originalsourceid>FETCH-LOGICAL-c281t-296376e3b0c9d900fa7ea0f69d926c150b51da928ed823d877147c6d146e789d3</originalsourceid><addsrcrecordid>eNpFkM9LxDAQhYP4a129ePbQkwehOpOkSXt0F1eFBUEUvJW0mUql2a5Je9j_3kgXPQ0ffDzePMYuEW4RQN8tVgASdC7lAZuhFFmqgX8cshmAylIVnVN2FsJXRBBSn7BjgYhKzRivaDDpq9klgyczONoMSd8kznTt58ZEoG1bjV1lfOKoM5vemXN21Jgu0MX-ztn76uFt-ZSuXx6fl_frtOY5DikvlNCKRAV1YQuAxmgy0KgIXNWYQZWhNQXPyeZc2FxrlLpWFqUinRdWzNn1lLv1_fdIYShdG2rqYgvqx1Dq-CfyAqN4M4m170Pw1JRb3zrjdyVC-btP-b9PlK_2qWPlyP6p0yDiB7SNXdU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>74351291</pqid></control><display><type>article</type><title>beta-Ray treatment of malignant epibulbar melanoma</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Lommatzsch, P K</creator><creatorcontrib>Lommatzsch, P K</creatorcontrib><description>Sixty-eight patients suffering from conjunctival melanoma were treated by beta-irradiation. The dose given ranged between 15,000 and 20,000 rd at the tumor surface. In 75% the therapy was successful. In 67,4% the melanoma could be cured by beta-irradiation alone with a follow-up period between three and ten years. The lethality rate from proven metastases was only 6.2%. The regression time after beta-therapy, as a rule, exceeded several months. Beta-rays can be used either primarily or after tumor excision. Care should be taken that the applicator covers all the tissue containing tumor cells.</description><identifier>ISSN: 0065-6100</identifier><identifier>EISSN: 1435-702X</identifier><identifier>DOI: 10.1007/BF00407844</identifier><identifier>PMID: 311166</identifier><language>eng</language><publisher>Germany</publisher><subject>Adolescent ; Adult ; Aged ; Child ; Conjunctiva ; Eye Neoplasms - etiology ; Eye Neoplasms - radiotherapy ; Eye Neoplasms - surgery ; Female ; Follow-Up Studies ; Humans ; Male ; Melanoma - etiology ; Melanoma - radiotherapy ; Melanoma - surgery ; Middle Aged ; Nevus, Pigmented - complications ; Precancerous Conditions ; Radiotherapy Dosage ; Strontium Radioisotopes - therapeutic use</subject><ispartof>Albrecht von Graefes Archiv f r Klinische und Experimentelle Ophthalmologie, 1978-12, Vol.209 (2), p.111-124</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c281t-296376e3b0c9d900fa7ea0f69d926c150b51da928ed823d877147c6d146e789d3</citedby><cites>FETCH-LOGICAL-c281t-296376e3b0c9d900fa7ea0f69d926c150b51da928ed823d877147c6d146e789d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/311166$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lommatzsch, P K</creatorcontrib><title>beta-Ray treatment of malignant epibulbar melanoma</title><title>Albrecht von Graefes Archiv f r Klinische und Experimentelle Ophthalmologie</title><addtitle>Albrecht Von Graefes Arch Klin Exp Ophthalmol</addtitle><description>Sixty-eight patients suffering from conjunctival melanoma were treated by beta-irradiation. The dose given ranged between 15,000 and 20,000 rd at the tumor surface. In 75% the therapy was successful. In 67,4% the melanoma could be cured by beta-irradiation alone with a follow-up period between three and ten years. The lethality rate from proven metastases was only 6.2%. The regression time after beta-therapy, as a rule, exceeded several months. Beta-rays can be used either primarily or after tumor excision. Care should be taken that the applicator covers all the tissue containing tumor cells.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Child</subject><subject>Conjunctiva</subject><subject>Eye Neoplasms - etiology</subject><subject>Eye Neoplasms - radiotherapy</subject><subject>Eye Neoplasms - surgery</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Melanoma - etiology</subject><subject>Melanoma - radiotherapy</subject><subject>Melanoma - surgery</subject><subject>Middle Aged</subject><subject>Nevus, Pigmented - complications</subject><subject>Precancerous Conditions</subject><subject>Radiotherapy Dosage</subject><subject>Strontium Radioisotopes - therapeutic use</subject><issn>0065-6100</issn><issn>1435-702X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1978</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM9LxDAQhYP4a129ePbQkwehOpOkSXt0F1eFBUEUvJW0mUql2a5Je9j_3kgXPQ0ffDzePMYuEW4RQN8tVgASdC7lAZuhFFmqgX8cshmAylIVnVN2FsJXRBBSn7BjgYhKzRivaDDpq9klgyczONoMSd8kznTt58ZEoG1bjV1lfOKoM5vemXN21Jgu0MX-ztn76uFt-ZSuXx6fl_frtOY5DikvlNCKRAV1YQuAxmgy0KgIXNWYQZWhNQXPyeZc2FxrlLpWFqUinRdWzNn1lLv1_fdIYShdG2rqYgvqx1Dq-CfyAqN4M4m170Pw1JRb3zrjdyVC-btP-b9PlK_2qWPlyP6p0yDiB7SNXdU</recordid><startdate>19781215</startdate><enddate>19781215</enddate><creator>Lommatzsch, P K</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19781215</creationdate><title>beta-Ray treatment of malignant epibulbar melanoma</title><author>Lommatzsch, P K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c281t-296376e3b0c9d900fa7ea0f69d926c150b51da928ed823d877147c6d146e789d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1978</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Child</topic><topic>Conjunctiva</topic><topic>Eye Neoplasms - etiology</topic><topic>Eye Neoplasms - radiotherapy</topic><topic>Eye Neoplasms - surgery</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Melanoma - etiology</topic><topic>Melanoma - radiotherapy</topic><topic>Melanoma - surgery</topic><topic>Middle Aged</topic><topic>Nevus, Pigmented - complications</topic><topic>Precancerous Conditions</topic><topic>Radiotherapy Dosage</topic><topic>Strontium Radioisotopes - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lommatzsch, P K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Albrecht von Graefes Archiv f r Klinische und Experimentelle Ophthalmologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lommatzsch, P K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>beta-Ray treatment of malignant epibulbar melanoma</atitle><jtitle>Albrecht von Graefes Archiv f r Klinische und Experimentelle Ophthalmologie</jtitle><addtitle>Albrecht Von Graefes Arch Klin Exp Ophthalmol</addtitle><date>1978-12-15</date><risdate>1978</risdate><volume>209</volume><issue>2</issue><spage>111</spage><epage>124</epage><pages>111-124</pages><issn>0065-6100</issn><eissn>1435-702X</eissn><abstract>Sixty-eight patients suffering from conjunctival melanoma were treated by beta-irradiation. The dose given ranged between 15,000 and 20,000 rd at the tumor surface. In 75% the therapy was successful. In 67,4% the melanoma could be cured by beta-irradiation alone with a follow-up period between three and ten years. The lethality rate from proven metastases was only 6.2%. The regression time after beta-therapy, as a rule, exceeded several months. Beta-rays can be used either primarily or after tumor excision. Care should be taken that the applicator covers all the tissue containing tumor cells.</abstract><cop>Germany</cop><pmid>311166</pmid><doi>10.1007/BF00407844</doi><tpages>14</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0065-6100 |
| ispartof | Albrecht von Graefes Archiv f r Klinische und Experimentelle Ophthalmologie, 1978-12, Vol.209 (2), p.111-124 |
| issn | 0065-6100 1435-702X |
| language | eng |
| recordid | cdi_crossref_primary_10_1007_BF00407844 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Adolescent Adult Aged Child Conjunctiva Eye Neoplasms - etiology Eye Neoplasms - radiotherapy Eye Neoplasms - surgery Female Follow-Up Studies Humans Male Melanoma - etiology Melanoma - radiotherapy Melanoma - surgery Middle Aged Nevus, Pigmented - complications Precancerous Conditions Radiotherapy Dosage Strontium Radioisotopes - therapeutic use |
| title | beta-Ray treatment of malignant epibulbar melanoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T01%3A20%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=beta-Ray%20treatment%20of%20malignant%20epibulbar%20melanoma&rft.jtitle=Albrecht%20von%20Graefes%20Archiv%20f%20r%20Klinische%20und%20Experimentelle%20Ophthalmologie&rft.au=Lommatzsch,%20P%20K&rft.date=1978-12-15&rft.volume=209&rft.issue=2&rft.spage=111&rft.epage=124&rft.pages=111-124&rft.issn=0065-6100&rft.eissn=1435-702X&rft_id=info:doi/10.1007/BF00407844&rft_dat=%3Cproquest_cross%3E74351291%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=74351291&rft_id=info:pmid/311166&rfr_iscdi=true |